Inhibitor Therapeutics, Inc. (INTI) stock
INTIOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.11+0.00 (+0.09%)
Close on Oct 19, 2026Market cap $19.06MP/E –Yield –
Inhibitor Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Inhibitor Therapeutics's enterprise value was $18.65M on Oct 19, 2026, against $4.97M a year earlier. Over the last 5 years it ranged from -$5.97M to $59.51M, with a median of $6.89M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $18.65M | +283.7% |
| 2025 | Dec 31, 2025 | $4.86M | +22.2% |
| 2024 | Dec 31, 2024 | $3.98M | -36.7% |
| 2023 | Dec 29, 2023 | $6.29M | -83.1% |
| 2022 | Dec 30, 2022 | $37.26M | -33.9% |
| 2021 | Dec 31, 2021 | $56.33M | +331.9% |
| 2020 | Dec 31, 2020 | $13.04M | -32.7% |
| 2019 | Dec 31, 2019 | $19.37M | -6.7% |
| 2018 | Dec 31, 2018 | $20.76M | -77.4% |
| 2017 | Dec 29, 2017 | $91.88M | -19.1% |
| 2016 | Dec 30, 2016 | $113.58M | +270.6% |
| 2015 | Dec 31, 2015 | $30.65M | +17.7% |
| 2014 | Dec 31, 2014 | $26.05M | +1582.1% |
| 2013 | Dec 31, 2013 | $1.55M | – |
See a number that looks wrong?